CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Fentanyl buccal

Last Updated: June 10, 2016
Result type: Reports
Project Number: SR0494-000
Product Line: Reimbursement Review

Generic Name: Fentanyl buccal

Brand Name: Fentora

Manufacturer: Teva Canada Innovation

Therapeutic Area: Pain (breakthrough), cancer (adults)

Indications: Pain (breakthrough), cancer (adults)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: February 21, 2017

Recommendation Type: Do not reimburse